Rare Disease Foundations
Supporting foundations with the infrastructure and expertise needed to protect patient samples and move research forward.
Rare disease research depends on something irreplaceable: patient samples. Every tube represents a family’s hope, a scientist’s breakthrough, and a community’s urgency.
Sampled partners with rare disease foundations to provide secure, compliant storage and advanced analytical services that transform carefully collected samples into high-quality, actionable data.
Our integrated biorepository and laboratory infrastructure ensures that samples are protected, processed, and analyzed with the precision these programs demand.
Comprehensive Biobanking Services
Our CAP-accredited biorepository supports long-term storage of diverse sample types under rigorously controlled conditions.
Whether storing materials for weeks, months, or years, we maintain full chain of custody, temperature monitoring, and regulatory compliance to safeguard every sample.
Kitting and Logistics Support
Sampled designs and supplies custom collection kits that foundations and clinical partners use to collect patient samples in a safe, standardized manner. Our kitting solutions are built to align with protocol requirements and ensure consistent handling from the point of collection through shipment to our facility.
We manage kit assembly, distribution, tracking, and return logistics to simplify coordination across sites while preserving sample integrity from collection through analysis.
Advanced Multiomic Laboratory Solutions
We offer both CLIA-validated and Research Use Only laboratory services to support comprehensive molecular analysis, including:
- Whole-genome sequencing and whole-exome sequencing
- Methylation sequencing and ATAC-seq
- Integrated multiomic workflows
Our platform capabilities include Illumina, PacBio, 10x Genomics, and Olink technologies, enabling scalable programs tailored to each foundation’s scientific goals.
Our Partners
The Ara Parseghian Medical Research Fund
Inspiring hope through research and awareness
Indiana, USA
Visit parseghianfund.nd.edu
The Ara Parseghian Medical Research Fund (APMRF) at the University of Notre Dame supports research into Niemann-Pick Type C (NPC), a rare genetic disease that affects approximately 1 in 100,000 people.
The fund was established in 1994 after Cindy and Mike Parseghian’s three children — Michael, Marcia, and Christa — were diagnosed with NPC. The foundation was named in honor of the children’s grandfather, Ara Parseghian, the legendary former Notre Dame football coach.
NPC is a lysosomal storage disorder caused by mutations in the NPC1 or NPC2 genes. These mutations impair the body’s ability to transport cholesterol properly, leading to its accumulation in lysosomes and reducing its availability for essential cellular functions and membrane formation. The disease presents with a wide range of symptoms and causes progressive neurological decline that is ultimately fatal, often during adolescence or early adulthood.
Research funded by the APMRF focuses on advancing new treatment strategies and ultimately finding a cure for NPC. Supported projects include newborn screening initiatives, therapies designed to correct NPC1 protein folding defects, and the development of biomarkers to improve NPC diagnosis.
More about us
Meet the team
Within our Executive Team alone we have over 180 years of cumulative experience in life sciences and healthcare, we know how to take care of your samples
Clients & Partners
We serve as the federal biorepository for four NIH institutes and multiple foundations.
Careers at Sampled
We’re always on the look out for the right people to make Sampled stronger. View vacancies here
